Docetaxel Injection

Product description

It is used  for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.

Strength: 20mg/1ml; 80mg/4ml;160mg/8ml---US FDA and CFDA approved.
Strength: 20mg/0.5 ml Single-dose Vial, Two-Vial Formulation (Injection Concentrate and Diluent)---US FDA and CFDA approved.
Read more

Specifications

Categories Finished Dosage FormsInjectables; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Docetaxel Injection

Contact information

Address

Telephone

Website

View all contact information